jardiance chronic kidney disease fda approval, lilly boehringer jardiance kidney disease, jardiance vs farxiga kidney disease, jardiance kidney disease trial results, jardiance kidney disease indication, jardiance kidney disease benefits, jardiance kidney disease market

Jardiance gets FDA green light for chronic kidney disease, challenging AstraZeneca’s rival drug

Anika Sharma

Shortly after securing European approval for the treatment of chronic kidney disease (CKD), Eli Lilly and Boehringer Ingelheim have achieved ...

:AstraZeneca, Farxiga, Wegovy, Novo Nordisk, Heart failure, heart failure and preserved ejection fraction

AstraZeneca’s Farxiga confident of its edge over Novo’s Wegovy in heart failure market

Anika Sharma

Novo Nordisk’s semaglutide and AstraZeneca’s Farxiga assuming the roles of formidable contenders. The arena is no longer confined to blood ...

AstraZeneca, Farxiga, heart failure, Chronic kidney diseases, European Society of Cardiology

Unveiling the Intricate Symphony: AstraZeneca’s Farxiga at the Heart of Cardiorenal Insights

Anika Sharma

In the heart of Amsterdam, amidst the captivating backdrop of the European Society of Cardiology (ESC) scientific sessions, AstraZeneca wielded ...

Farxiga, Forxiga, Diabetes, Chronic Heart Failure, SGLT2 inhibitors, Chronic Kidney diseases, Farxiga price, Farxiga cost, Forxiga Cost, Forxiga price, Forxiga approval

Farxiga/Forxiga: Drug for Diabetes, Heart Failure and Kidney Disease

Anika Sharma

Farxiga is a brand name in the United States and Forxiga is the brand name in Europe and other countries. ...